Literature DB >> 22274591

Downregulation of protein tyrosine phosphatase PTPL1 alters cell cycle and upregulates invasion-related genes in prostate cancer cells.

Carolina Castilla1, M Luz Flores, José M Conde, Rafael Medina, Francisco J Torrubia, Miguel A Japón, Carmen Sáez.   

Abstract

PTPL1, a non-receptor type protein tyrosine phosphatase, has been involved in the regulation of apoptosis and invasiveness of various tumour cell types, but its role in prostate cancer remained to be investigated. We report here that downregulation of PTPL1 by small interfering RNA in PC3 cells decreases cell proliferation and concomitantly reduces the expression of cell cycle-related proteins such as cyclins E and B1, PCNA, PTTG1 and phospho-histone H3. PTPL1 downregulation also increases the invasion ability of PC3 cells through Matrigel coated membranes. cDNA array of PTPL1-silenced PC3 cells versus control cells showed an upregulation of invasion-related genes such as uPA, uPAR, tPA, PAI-1, integrin α6 and osteopontin. This increased expression was also confirmed in PTPL1-silenced DU145 prostate cancer cells by quantitative real time PCR and western blot. These findings suggest that PTPL1 is an important mediator of central cellular processes such as proliferation and invasion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22274591     DOI: 10.1007/s10585-012-9455-7

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  36 in total

1.  Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product.

Authors:  F Ramos-Morales; A Domínguez; F Romero; R Luna; M C Multon; J A Pintor-Toro; M Tortolero
Journal:  Oncogene       Date:  2000-01-20       Impact factor: 9.867

2.  Osteopontin and interleukin-8 expression is independently associated with prostate cancer recurrence.

Authors:  Daniel J Caruso; Adrienne J K Carmack; Vinata B Lokeshwar; Robert C Duncan; Mark S Soloway; Bal L Lokeshwar
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

Review 3.  PTPN13/PTPL1: an important regulator of tumor aggressiveness.

Authors:  Gilles Freiss; Dany Chalbos
Journal:  Anticancer Agents Med Chem       Date:  2011-01       Impact factor: 2.505

Review 4.  The role of tumor microenvironment in prostate cancer bone metastasis.

Authors:  Colm Morrissey; Robert L Vessella
Journal:  J Cell Biochem       Date:  2007-07-01       Impact factor: 4.429

5.  Integrin alpha6 cleavage: a novel modification to modulate cell migration.

Authors:  Sangita C Pawar; Manolis C Demetriou; Raymond B Nagle; G Tim Bowden; Anne E Cress
Journal:  Exp Cell Res       Date:  2007-01-17       Impact factor: 3.905

6.  RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.

Authors:  Sai MuraliKrishna Pulukuri; Christopher S Gondi; Sajani S Lakka; Aman Jutla; Norman Estes; Meena Gujrati; Jasti S Rao
Journal:  J Biol Chem       Date:  2005-08-26       Impact factor: 5.157

Review 7.  Osteopontin: role in cell signaling and cancer progression.

Authors:  Hema Rangaswami; Anuradha Bulbule; Gopal C Kundu
Journal:  Trends Cell Biol       Date:  2006-01-10       Impact factor: 20.808

Review 8.  The plasminogen activation system in tumor growth, invasion, and metastasis.

Authors:  P A Andreasen; R Egelund; H H Petersen
Journal:  Cell Mol Life Sci       Date:  2000-01-20       Impact factor: 9.261

9.  Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.

Authors:  Amit Gupta; Yair Lotan; Raheela Ashfaq; Claus G Roehrborn; Ganesh V Raj; Corinne C Aragaki; Francesco Montorsi; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2008-06-23       Impact factor: 20.096

10.  PTPL1/FAP-1 negatively regulates TRIP6 function in lysophosphatidic acid-induced cell migration.

Authors:  Yun-Ju Lai; Weei-Chin Lin; Fang-Tsyr Lin
Journal:  J Biol Chem       Date:  2007-06-25       Impact factor: 5.157

View more
  7 in total

1.  MiRNA-494 inhibits metastasis of cervical cancer through Pttg1.

Authors:  Bing Chen; Zhaohui Hou; Chundong Li; Ying Tong
Journal:  Tumour Biol       Date:  2015-04-16

2.  Valosin containing protein (VCP/p97) is a novel substrate for the protein tyrosine phosphatase PTPL1.

Authors:  Ogan D Abaan; Wiljan Hendriks; Aykut Uren; Jeffrey A Toretsky; Hayriye V Erkizan
Journal:  Exp Cell Res       Date:  2012-09-24       Impact factor: 3.905

3.  Lentivirus vector-mediated knockdown of erythropoietin-producing hepatocellular carcinoma receptors B4 inhibits laser-induced choroidal neovascularization.

Authors:  Jing Du; Wei Zhao; Yusheng Wang; Yan Cai
Journal:  J Ocul Pharmacol Ther       Date:  2012-10-04       Impact factor: 2.671

4.  Tumour-suppressive role of PTPN13 in hepatocellular carcinoma and its clinical significance.

Authors:  Hao Zhan; Jiahao Jiang; Chubin Luo; Qiman Sun; Aiwu Ke; Chao Sun; Jinwu Hu; Zhiqiang Hu; Bo Hu; Kai Zhu; Jia Fan; Jian Zhou; Xiaowu Huang
Journal:  Tumour Biol       Date:  2016-01-23

5.  EphrinB1: novel microtubule associated protein whose expression affects taxane sensitivity.

Authors:  Paul L Colbert; Daniel W Vermeer; Bryant G Wieking; John H Lee; Paola D Vermeer
Journal:  Oncotarget       Date:  2015-01-20

6.  PTPN13 induces cell junction stabilization and inhibits mammary tumor invasiveness.

Authors:  Mohamed Hamyeh; Florence Bernex; Romain M Larive; Aurélien Naldi; Serge Urbach; Joelle Simony-Lafontaine; Carole Puech; William Bakhache; Jérome Solassol; Peter J Coopman; Wiljan J A J Hendriks; Gilles Freiss
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

Review 7.  Dual Role of the PTPN13 Tyrosine Phosphatase in Cancer.

Authors:  Soha Mcheik; Leticia Aptecar; Peter Coopman; Véronique D'Hondt; Gilles Freiss
Journal:  Biomolecules       Date:  2020-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.